Search
After immunotherapy and targeted therapy failed to bring a patient's melanoma under control, MSK doctors offered her a new treatment called tumor-infiltrating lymphocyte, or TIL, therapy.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantationoutcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease.
Learn the keys to a successful telemedicine visit from a cancer specialist at Memorial Sloan Kettering.
Aprenda las claves para una visita de telemedicina exitosa de parte de una especialista en cáncer en Memorial Sloan Kettering.
Узнайте о том, что необходимо для успешного дистанционного приема, от онколога центра Memorial Sloan Kettering.
A new discovery made by Memorial Sloan Kettering researchers and published in the journal Nature Genetics, identifies a mechanism for the triggering of solid tumors — including most types of cancers that affect children and young adults. For more information or to arrange interviews, e-mail Rebecca Williams at [email protected].
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."
New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.